Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics.
about
Dose finding studies with imidapril--a new ACE inhibitor.Pharmacokinetic and pharmacodynamic interactions between the ACE inhibitor cilazapril and beta-adrenoceptor antagonist propranolol in healthy subjects and in hypertensive patients.Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers.The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording.Comparison of four basic models of indirect pharmacodynamic responsesHow often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?Impact of disease states on the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors.Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.Angiotensin-converting enzyme inhibitors: mechanistic controversies.Pharmacokinetics of angiotensin converting enzyme inhibitors.Attenuation by ACE inhibitor drugs of alpha-adrenoceptor sensitivity in human vessels: possible differences related to drug lipophilicity.Role of ACE inhibitors in hypertension complicated by vascular disease.Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).Pharmacokinetics and biochemical efficacy of idrapril calcium, a novel ACE inhibitor, after multiple oral administration in humans.The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazapril.Inhibition of serum angiotensin-converting enzyme in rabbits after intravenous administration of enalaprilat-loaded intact erythrocytes.Relationship of serum ACE inhibition to oral dose of enalapril in normotensive volunteers.Once-daily trandolapril compared with the twice-daily formulation in the treatment of mild to moderate essential hypertension: assessment by conventional and ambulatory blood pressures.Cardiovascular and hormonal responses to ANP infusion in the guinea-pig: effects of angiotensin-converting enzyme inhibition with perindopril.
P2860
Q24538596-09911EA4-7617-4D0E-BCE7-4301046FD851Q28342002-163E51F8-6EA2-4767-AB55-5AC2E9EC388FQ33611337-70B7C8E0-4EF8-4585-B114-616341EE8CB8Q34347473-C87E8EA6-E245-4C02-8F19-6E00D9EDB5C9Q34358706-7C722FA5-95BA-4500-AFC2-63BB724D3D12Q34392881-D9207AFB-16D5-4E8E-8EC5-7266704918A2Q35372794-40824EF7-6DB5-4A2B-BB78-B735646916ECQ36571898-C35D383B-50C5-444B-A4AE-6EE95C9BBA33Q37170615-A83A957F-D3C6-4B40-9D77-50F35FF68811Q38320456-AF1C93FD-646D-4A3D-A013-85F42F8B467FQ38747844-1BC994FA-5463-4C3E-8B89-F1BF1997B28CQ41778874-40893D3D-1E8B-4D8F-9182-2979C44FE4AAQ41824859-1EF14AF0-5DF1-4125-A733-3E2761DBAEDDQ42068724-54F7F01F-3DFC-444B-B3BD-C8E1D53DDB51Q43201714-2470D7AB-287D-44AB-BE31-DD0B6D99559FQ43222328-4FA266B7-0040-44EB-8CFD-29EE44AE0A4CQ43751561-147840CE-723E-4236-BA8B-42606A8FF4C8Q43970879-ED7CDAB3-F176-486E-A5C6-6B94F2ED0180Q48863581-2E2D1D96-A442-41A5-A2E0-06AD4E20D9C7Q53848266-096404FE-F6BE-45D8-88FE-F864F1BF6FE9
P2860
Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Angiotensin-converting enzyme ...... dynamics and pharmacokinetics.
@en
Angiotensin-converting enzyme ...... dynamics and pharmacokinetics.
@nl
type
label
Angiotensin-converting enzyme ...... dynamics and pharmacokinetics.
@en
Angiotensin-converting enzyme ...... dynamics and pharmacokinetics.
@nl
prefLabel
Angiotensin-converting enzyme ...... dynamics and pharmacokinetics.
@en
Angiotensin-converting enzyme ...... dynamics and pharmacokinetics.
@nl
P2093
P1476
Angiotensin-converting enzyme ...... dynamics and pharmacokinetics.
@en
P2093
C H Kleinbloesem
P304
P356
10.2165/00003088-198815050-00003
P577
1988-11-01T00:00:00Z
P6179
1000916127